by PVA_Admin | May 12, 2022 | 2022 Press Release, Press Release
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology TAKOMA PARK, Md.–(BUSINESS WIRE)–Jerome Canady Research Institute...
by PVA_Admin | Mar 15, 2022 | 2022 Press Release, Press Release
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), announced today that their recent...
by PVA_Admin | Oct 6, 2021 | 2021 Press Release, Press Release
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological...
by PVA_Admin | Sep 9, 2021 | 2021 Press Release, Press Release
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a U.S....
by PVA_Admin | Sep 2, 2021 | 2021 Press Release, Press Release
JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), in collaboration with...
by PVA_Admin | May 5, 2021 | 2021 Press Release, Press Release
USMI Developing the First Surgical Robot for Cancer Surgery TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) announced today that it is developing the first robotic delivery system used for cancer surgery. The new Canady Surgical System...
